Vetter's Rankweil Site Completes First 100 Aseptic Fills

Vetter, a global CDMO, has successfully completed the first 100 clinical batches of liquid and lyophilized vials at its dedicated site in Rankweil, Austria. Vetter Development Services Austria supports the manufacturing and quality control of medicinal products for clinical trials.

In response to current growth, Vetter is further investing in its Rankweil site with the addition of a third floor to the building, creating more office space and meeting rooms. An additional 3,400 square-meter technical building will be built on the West side of the existing facility. This two-story building will house a technical workshop and a waste disposal center. Also, the basement of the building will feature an uninterrupted power supply system which prevents power disruptions for its operations.  
 
“It has been exciting few years for the Rankweil site,” said Dr. Martin Schwab, Vice President and Site Head Austria. “We look forward to witnessing this site continue to develop and grow. Our success is driven by a strong surge in project orders which will continue in the second half of the year. We are committed to further enhancing our clinical production efficiency in Rankweil, both through increased security initiatives, innovative technology, and a higher number of employees working at the site.”